NEW BIOMARKERS OF CARDIOVASCULAR ENDPOINTS AND HEART FAILURE PROGRESSION ANALYSIS AFTER MYOCARDIAL INFARCTION

Publication date: 2019

DOI: 10.1016/j.atherosclerosis.2019.06.509

Abstract:

Myocardial infarction (MI) is one of the main factors in heart failure (HF) progression. New and sensitive biomarkers such as ST2 and Pentraxin-3 (Ptx-3) have prediction potential in HF and primary cardiovascular endpoints prediction in the remote period.

Издатель: Elsevier Science Publishing Company, Inc.

Тип: Article